ENTEROCOCCAL BACTEREMIA - CLINICAL-FEATURES, THE RISK OF ENDOCARDITIS, AND MANAGEMENT

被引：275

作者：

MAKI, DG

AGGER, WA

机构：

[1] UNIV WISCONSIN,SCH MED,DEPT MED,INFECT DIS SECT,MADISON,WI 53706

[2] GUNDERSEN CLIN LTD,DEPT MED,INFECT DIS SECT,LA CROSSE,WI 54601

来源：

MEDICINE | 1988年 / 67卷 / 04期

关键词：

D O I：

10.1097/00005792-198807000-00005

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：248 / 269

页数：22

共 261 条

[1]

ABRUTYN E, 1978, J ANTIMICROB CHEMOTH, V2, P153

[2]

AGGER WA, 1978, J CLIN MICROBIOL, V7, P111

[3] EARLY ONSET NON-ENTEROCOCCAL GROUP-D STREPTOCOCCAL INFECTION IN NEWBORN-INFANT [J].

ALEXANDER, JB ;

GIACOIA, GP .

JOURNAL OF PEDIATRICS, 1978, 93 (03) :489-490

[4]

Andrewes FW, 1906, LANCET, V2, P852

[5]

Andrewes FW, 1906, LANCET, V2, P775

[6]

ANDREWS FW, 1906, LANCET, V2, P207

[7]

AUCKENTHALER R, 1982, ANTIMICROB AGENTS CH, V22, P447

[8]

BARRALL DT, 1985, ARCH SURG, V120, P5763

[9]

BARRY AL, 1979, AM J CLIN PATHOL, V72, P858

[10] ANTIBACTERIAL ACTIVITIES OF CIPROFLOXACIN, NORFLOXACIN, OXOLINIC ACID, CINOXACIN, AND NALIDIXIC-ACID [J].

BARRY, AL ;

JONES, RN ;

THORNSBERRY, C ;

AYERS, LW ;

GERLACH, EH ;

SOMMERS, HM .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 25 (05) :633-637

← 1 2 3 4 5 6 7 8 9 10 →